SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-053302
Filing Date
2023-10-13
Accepted
2023-10-13 16:05:27
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-20230930.htm   iXBRL 10-Q 1644014
2 EX-10.1 alrn-ex10_1.htm EX-10.1 27758
3 EX-31.1 alrn-ex31_1.htm EX-31.1 15333
4 EX-31.2 alrn-ex31_2.htm EX-31.2 14874
5 EX-32.1 alrn-ex32_1.htm EX-32.1 9420
6 EX-32.2 alrn-ex32_2.htm EX-32.2 8025
  Complete submission text file 0000950170-23-053302.txt   6195031

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alrn-20230930_cal.xml EX-101.CAL 34506
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alrn-20230930_def.xml EX-101.DEF 126898
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alrn-20230930.xsd EX-101.SCH 37494
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alrn-20230930_pre.xml EX-101.PRE 246817
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alrn-20230930_lab.xml EX-101.LAB 349862
55 EXTRACTED XBRL INSTANCE DOCUMENT alrn-20230930_htm.xml XML 1044031
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 231325133
SIC: 2834 Pharmaceutical Preparations